In vitro biomimetic HPLC and in vivo characterisation of GM6, an endogenous regulator peptide drug candidate for amyotrophic lateral sclerosis. ADMET and DMPK, [S. l.], v. 6, n. 2, p. 176–189, 2018. DOI: 10.5599/admet.547. Disponível em: https://pub.iapchem.org/ojs/index.php/admet/article/view/547. Acesso em: 21 may. 2026.